Geron Corp at Needham Healthcare Conference (Virtual) Transcript
Good afternoon and welcome to day three of the Needham & Company healthcare conference. My name is Gil Blum, and I am a senior biotech analyst here at Needham & Company. It is my pleasure to have with me today Geron management team. (Conference Instructions)
And with that, Chip, you have the stage.
Thanks a lot, Gil, and good afternoon, everyone. I am Chip Scarlett; I'm the Chairman and CEO of Geron Corporation. I'm delighted to be here representing my colleagues at Geron. And I would like to thank the organizers and Gil, in particular, for inviting me to speak today.
Next slide, please. During the course of this presentation and question-and-answer session, there will be forward-looking statements regarding future events, performance, plans, expectations, and other projections, including those relating to the therapeutic potential of and potential regulatory approval of imetelstat, anticipated clinical and commercial
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |